Re: Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery

Eur Urol. 2016 May;69(5):964-5. doi: 10.1016/j.eururo.2016.02.011.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Male
  • Prostate-Specific Antigen*
  • Prostatic Neoplasms / epidemiology*
  • Watchful Waiting

Substances

  • Prostate-Specific Antigen